Orelle Corporation Announces Conclusion of Phase II Clinical Trials

SEATTLE--(BUSINESS WIRE)--Orelle Corporation of Seattle, Washington, winner of the Price Waterhouse ‘Investor Choice Award for Best Pre-Revenue Company’ at the Vancouver, BC Angel Forum in June ‘08, announces the conclusion of Phase II Clinical Trials at the Auckland University of Technology in New Zealand related to Orelle’s Pelvic Floor Muscle Exercise Device and associated Exercise Program for the Relief and Prevention of Urinary Stress Leakage in Women.

Back to news